Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery.
Sign Up to like & getrecommendations! Published in 2022 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.1c00996
Abstract: Glioblastoma (GB) is recognized as the most aggressive form of primary brain cancer. Despite advances in treatment strategies that include surgery, radiation, and chemotherapy, the median survival time (∼15 months) of patients with GB has… read more here.
Keywords: target glioblastoma; glioblastoma overcoming; antibody based; based formats ... See more keywords